From maximizing success with milestone-based development to leveraging global operations for lower costs, strategic partnerships can revolutionize clinical research. Download our full white paper now to learn more about the benefits of these collaborations: https://ow.ly/2g6X50Sxeoo
Worldwide Clinical Trials’ Post
More Relevant Posts
-
When do publications perform? In poster 26 at #ISMPPEurope2024, we evaluated real-world publication performance across therapy areas, article types and publication enhancements. In collaboration with Ipsen, our aim was to evaluate publication performance systematically at different time points to determine benchmarks for future performance evaluation and to inform publication strategy. Our analyses suggested that there is a high benchmark for future primary research and systematic literature reviews (SLRs) regarding impact. From a strategic perspective, our data show that building enhancements into publication planning may be worthwhile, and that SLRs could be strategically important publication types. Interested in learning more? View the poster here. Poster authors: Hollie Rawlings, Lorna Blackwell, Claire Loane and Charles Pollitt. https://lnkd.in/esEW_Uyj #ExploreNewFrontiers #HealthScience #MedicalAffairs #ISMPPEurope2024
Measuring real-world publication performance across therapy areas, article types, and publication enhancements
ipsen.congressposter.com
To view or add a comment, sign in
-
If your study team is overwhelmed by the latest innovations in clinical trials, our on-demand webinar will help you to understand the role of new technologies in optimizing study strategies, and how a robust data ecosystem can help. Watch now. https://bit.ly/4ajVPpO #clinicaltrials
To view or add a comment, sign in
-
We’re thrilled about the FDA's latest guidance on using real-world evidence in observational research. Our latest blog explores how this guidance offers clarity, and identifies four key areas where additional information will benefit the evolving industry. Discover our insights on the future of observational research: https://lnkd.in/ejNnh5wP #artificialintelligence #realworlddata #patientcentricity #observationalresearch
To view or add a comment, sign in
-
Broadening the scope of research and continuing with decentralized methods of data collection will continue to be important in clinical trials this year. Check it out here: https://bit.ly/3UvFVV0
To view or add a comment, sign in
-
If your study team is overwhelmed by the latest innovations in clinical trials, our on-demand webinar will help you to understand the role of new technologies in optimizing study strategies, and how a robust data ecosystem can help. Watch now. https://bit.ly/3MwLDRA #clinicaltrials
To view or add a comment, sign in
-
📢AGENDA RELEASED for the Global Clinical Trial Disclosure and Data Transparency Conference! Join us for this essential event where industry leaders and experts will delve into the latest in #clinical #trialdisclosure and #datatransparency. From #regulatory updates to best practices in data sharing, this conference is a must-attend for anyone committed to advancing #transparency in #clinicalresearch. View #CTD24 agenda at: https://ow.ly/GJxN50SCEUW
Agenda Released! Explore All Sessions
diaglobal.org
To view or add a comment, sign in
-
Online research consent forms are crucial for obtaining informed consent in research. 🕵️♂️ Delve into this article to discover insights and valuable tips on their creation! https://lnkd.in/dWc9v_Gg #research #consent #form
To view or add a comment, sign in
-
Very interesting upcoming webinar by Intelligencia AI on August 28th, touching on how to increase R&D ROI with AI-driven assessments, strategies to identify indications for asset success using clinical developments, and methods to help reduce biases. Don't miss out on this one - make sure to register now!
Register for our upcoming webinar https://lnkd.in/eHZVGYeg and hear from industry leaders John McGrath, Josh Hattem, Ivan Kugener, MD and Panos Karelis on: 🧠 How to increase R&D ROI, accelerate time to market and inform smarter investments using AI-driven PTRS assessments. 🧠 Strategies to identify indications that present the best chances for certain types of assets to succeed using the latest clinical developments 🧠 Methods to help reduce inherent biases by incorporating quantitative rigor into decision-making. Register here https://lnkd.in/eHZVGYeg
To view or add a comment, sign in
-
Check out the new ConsentTools toolkit developed by NIH-funded researchers to improve informed consent practices in #ClinicalResearch! Learn more and spread the word: https://ow.ly/ILAb50QSztL #CTSAProgram
To view or add a comment, sign in
-
For my PhD project, I recently put together the attached infographic, which provides a brief introduction to the differences between Traditional and Decentralised Clinical Trials. I'm sharing it in case it helps others to understand or explain the options and the sliding scale on which they can operate #DCT #decentralizedclinicaltrials #flexibletrialdelivery #telehealth
Have you ever been confused about what a Decentralised Clinical Trial actually is? You're not alone! It's a topic I find myself explaining multiple times a week to researchers, industry, and consumers alike. To help with a recent research project, I created an infographic that I have posted over on our resource hub that can help to clarify the different methods of clinical trials or could assist in explaining it to others #DCT #decentralizedclinicaltrials https://bit.ly/101DCT
Research 101: Traditional vs Decentralised Clinical Trials
majorresearch.com.au
To view or add a comment, sign in
170,252 followers
Felix Perez, CEO Research Director
3moExited to discover how strategic partnerships can transform clinical research! Downloading the white paper today for valuable insights.